Synergistic anticancer efficacy of curcumin and doxorubicin combination treatment inducing s-phase cell cycle arrest in triple-negative breast cancer cells: an in vitro study

HIGHLIGHTS

• What: The authors observed the dose-dependent cytotoxicity increased reactive oxygen species (ROS) generation and increased chromatin condensation in combination doses compared to single doses. This study focuses on Cur chemosensitizing apoptosis in the MDA-MB-231 cell line in combination with Doxo. Based on the numerous previously reported successful preclinical and clinical trials , the authors intended to investigate the cascade mechanism of Cur`s anticancer efficacy.
• Who: from the Department of Biochemistry, Era`s Lucknow Medical College and Hospital, Era University, Lucknow, IND have published the research work: Review began 11/08/2024 Review . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.